Can Pediatrix Sustain Growth Despite Lower Patient Volumes?
MD posts 4% year-over-year revenue growth in the second quarter of 2026 despite lower patient volumes, aided by stronger reimbursement and acquisitions.
Zacks
Can Pediatrix Sustain Growth Despite Lower Patient Volumes?
MD posts 4% year-over-year revenue growth in the second quarter of 2026 despite lower patient volumes, aided by stronger reimbursement and acquisitions.
Zacks
More News
Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue?
Cencora (COR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio
MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its growth prospects.
Zacks
Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
Encompass Health Beats Q2 Earnings Estimates, Raises '26 View
EHC beats Q2 earnings estimates as higher patient revenues and strong discharge growth drive results, leading the company to raise its 2026 adjusted EPS outlook.
Zacks
Pediatrix Medical Tops Q2 Earnings on Better Cash Collections
MD posts a Q2 earnings beat as stronger cash collections and a favorable payor mix lift results despite lower volumes.